Identification of biomarkers that can predict cognitive decline is of utmost importance for advance in dementia pharmacotherapy. In this study, cerebral blood flow (CBF) is investigated as a predictor for cognitive decline in a healthy aging population. We found CBF in the frontal lobe to be most predictive for cognitive decline, specifically for episodic memory and in the older population. This suggest that CBF can be used as a biomarker to identify subjects susceptible to cognitive decline, to identify suitable cohorts for clinical trials, and to monitor the effects of pharmacotherapy.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords